Biogen Inc. (NASDAQ: BIIB) stock closed at 270.03 per share at the end of the most recent trading day (a 1.83% change compared to the prior day closing price) with a volume of 968.18K shares and market capitalization of 39.02B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 9100 people. Biogen Inc. CEO is Michel Vounatsos.

The one-year performance of Biogen Inc. stock is 24.49%, while year-to-date (YTD) performance is -2.49%. BIIB stock has a five-year performance of 3.81%. Its 52-week range is between 187.16 and 311.88, which gives BIIB stock a 52-week price range ratio of 66.44%

Biogen Inc. currently has a PE ratio of 14.20, a price-to-book (PB) ratio of 3.15, a price-to-sale (PS) ratio of 5.19, a price to cashflow ratio of 17.10, a PEG ratio of 2.32, a ROA of 12.73%, a ROC of 16.54% and a ROE of 26.51%. The company’s profit margin is 31.62%, its EBITDA margin is 40.40%, and its revenue ttm is $7.63 Billion , which makes it $52.98 revenue per share.

Of the last four earnings reports from Biogen Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $3.32 for the next earnings report. Biogen Inc.’s next earnings report date is 02nd May 2023.

The consensus rating of Wall Street analysts for Biogen Inc. is Moderate Buy (1.74), with a target price of $308.58, which is +14.28% compared to the current price. The earnings rating for Biogen Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biogen Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biogen Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.50, ATR14 : 6.27, CCI20 : 52.73, Chaikin Money Flow : 0.00, MACD : -2.97, Money Flow Index : 47.30, ROC : 2.67, RSI : 51.65, STOCH (14,3) : 91.97, STOCH RSI : 1.00, UO : 54.81, Williams %R : -8.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biogen Inc. in the last 12-months were: Ginger Gregory (Option Excercise at a value of $0), Ginger Gregory (Sold 5 610 shares of value $1 683 617 ), Michael R. Mcdonnell (Option Excercise at a value of $0), Nicole Murphy (Option Excercise at a value of $0), Priya Singhal (Option Excercise at a value of $0), Rachid Izzar (Option Excercise at a value of $0), Robin C. Kramer (Option Excercise at a value of $0), Susan H. Alexander (Option Excercise at a value of $0), Susan H. Alexander (Sold 5 532 shares of value $1 552 832 )